Press Releases

Press Releases

Date Title and Summary Additional Formats
Toggle Summary NeuroMetrix to Present at Canaccord Genuity 6th Annual Cardiovascular, Aesthetics & Metabolic Disorders Conference
NeuroMetrix to Present at Canaccord Genuity 6th Annual Cardiovascular, Aesthetics & Metabolic Disorders Conference WALTHAM, Mass. --(BUSINESS WIRE)--Nov. 29, 2011-- NeuroMetrix, Inc. (Nasdaq: NURO), a medical device company focused on the diagnosis and treatment of the neurological complications of
View HTML
Toggle Summary NeuroMetrix Reports Q3 2011 Results
Updates on NC-stat DPNCheck Commercial Launch
View HTML
Toggle Summary NeuroMetrix, Inc. Announces Date for 2011 Third Quarter Financial Results Conference Call
NeuroMetrix, Inc. Announces Date for 2011 Third Quarter Financial Results Conference Call WALTHAM, Mass., Oct 20, 2011 (BUSINESS WIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today said it plans to issue its 2011 third quarter financial results before the opening of the market on October 27, 2011.
View HTML
Toggle Summary NeuroMetrix Names Kenneth J. Snow, M.D. as Chief Medical Officer
NeuroMetrix Names Kenneth J. Snow, M.D. as Chief Medical Officer WALTHAM, Mass., Oct 04, 2011 (BUSINESS WIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today announced the appointment of Kenneth J. Snow, M.D. as Chief Medical Officer. The appointment was effective October 3, 2011.
View HTML
Toggle Summary NeuroMetrix Reports Compliance With NASDAQ Listing Requirements
NeuroMetrix Reports Compliance With NASDAQ Listing Requirements WALTHAM, Mass., Sep 19, 2011 (BUSINESS WIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today reported that it has received a letter from The NASDAQ Stock Market LLC ("NASDAQ") indicating that it has regained compliance with the minimum bid
View HTML
Toggle Summary NeuroMetrix Reports Product Milestone
Initiates Commercial Shipments of NC-stat DPNCheck
View HTML
Toggle Summary NeuroMetrix to Present at Rodman & Renshaw Annual Global Investment Conference
NeuroMetrix to Present at Rodman & Renshaw Annual Global Investment Conference WALTHAM, Mass., Sep 07, 2011 (BUSINESS WIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO), a science-based health care company improving patient care through neurotechnology, today announced that Shai N.
View HTML
Toggle Summary NeuroMetrix Announces One-for-Six Reverse Stock Split
Shares of Common Stock Will Begin Trading on a Split-Adjusted Basis on September 2, 2011
View HTML
Toggle Summary NeuroMetrix to Present at Canaccord Genuity Growth Conference
NeuroMetrix to Present at Canaccord Genuity Growth Conference WALTHAM, Mass., Aug 02, 2011 (BUSINESS WIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO), a science-based health care company improving patient care through neurotechnology, today announced that Shai N.
View HTML
Toggle Summary NeuroMetrix Reports Q2 2011 Results
Commercial NC-stat(R) DPNCheck(TM) Activity to Start During Q3
View HTML